7 studies were found.

1.		No longer recruiting	Carboplatin With or Without Gemcitabine in Treating Patients With Advanced Ovarian Epithelial Cancer That Has Not Responded to Previous Chemotherapy Condition: recurrent ovarian epithelial cancer
2.		No longer recruiting	Chemotherapy With or Without Surgery in Treating Patients With Recurrent Ovarian Cancer Condition: recurrent ovarian epithelial cancer
3.		Completed	Paclitaxel and Carboplatin With or Without Epirubicin in Treating Patients With Stage IIB, Stage III, or Stage IV Invasive Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer Conditions: stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; Fallopian Tube Cancer; ...
4.		No longer recruiting	Paclitaxel in Treating Patients With Refractory or Recurrent Endometrial Cancer Conditions: recurrent endometrial cancer; endometrial papillary carcinoma
5.		No longer recruiting	Pelvic Drains After Radical Hysterectomy in Treating Patients With Uterine, Cervical, or Vaginal Cancer Conditions: perioperative/postoperative complications; stage II cervical cancer; stage I cervical cancer; stage I endometrial cancer; stage II endometrial cancer; ...
6.		No longer recruiting	Radiation Therapy or No Further Treatment Following Surgery in Treating Patients With Cancer of the Uterus Conditions: uterine leiomyosarcoma; uterine carcinosarcoma; stage II uterine sarcoma; Endometrial Stromal Sarcoma; stage I uterine sarcoma
7.		No longer recruiting	Radiation Therapy With or Without Chemotherapy After Surgery in Treating Patients With Stage IB or Stage IIA Cervical Cancer Conditions: cervical squamous cell carcinoma; cervical adenocarcinoma; stage IB cervical cancer; stage IIA cervical cancer; cervical adenosquamous cell carcinoma